Adra Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -8.89%
(FY 2022)
- Ebitda -300.71%
(FY 2022)
- Net Worth -26.00%
(FY 2022)
- Total Assets 61.80%
(FY 2022)
About Adra Biotechnologies
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Sreedhar, Anilkumar Sivadasan, and Kamakshi Amma serve as directors at the Company.
- CIN/LLPIN
U73100KL2017PTC048283
- Company No.
048283
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Adra Biotechnologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sreedhar  | Additional Director | 24-Sep-2024 | Current |
| Anilkumar Sivadasan | Director | 15-Feb-2017 | Current |
| Kamakshi Amma | Director | 15-Feb-2017 | Current |
Financial Performance and Corporate Structure Insights of Adra Biotechnologies.
Adra Biotechnologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 8.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adra Biotechnologies?
Unlock access to Adra Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Professional Educational Network & Structures Private LimitedActive 8 years 3 months
Anil Sreedhar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adra Biotechnologies?
Unlock and access historical data on people associated with Adra Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adra Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adra Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
